Indication

View All

severe combined Immunodeficiency
Bubble Boy Syndrome (ADA-SCID) – A Rare Immunodeficiency Disorder

Severe Combined Immunodeficiency (SCID) is an inherited primary immunodeficiency disease (PIDD) that typically presents in infancy. It is characterized by profound immune deficiency condition resulting in a weak immune system that is unable to fight off even mild infections. Severe Combined Immunodeficiency is a rar...

Find More

Delveinsight
Our Formula For Mechanism Of Action Is So Effective We’d Patent It If We Could

DelveInsight's Mechanism of Action Reports has become the Success Reason for the Leading Pharma Companies In this competitive world, everybody wants to get aware of what others are doing in their sectors and what strategic drivers are followed by the others for the successful future milestones. But the drug ...

Find More

Delveinsight
Infectious Disease and Vaccines Pipeline Reports

DelveInsight is helping worldwide Pharmaceutical companies with its Market Intelligence Reports. VISIT OUR WEBSITE Infectious Diseases and Vaccines The infectious disease (ID) vaccine pipeline is rich and robust. However, indications such as HIV, Tuberculosis and HCV have high demand for the development of a fi...

Find More

Delveinsight
Metastatic Prostate Cancer-Pipeline Insights, 2014

The “ Metastatic Prostate Cancer-Pipeline Insights, 2014”, report by DelveInsight provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Metastatic Prostate Cancer. This report provides in...

Find More

Delveinsight
Delveinsight launched novel Drug Pipeline reports

Over the past six months, DelveInsight has proven its value to their customers with its excellent deliverables. Now newly launched DelveInsight's Pipeline Reports is the answer to all looking for top notch drug development information. In the fast-paced, competitive field of clinical research, organizations must...

Find More